H.C. Wainwright Reiterates Buy Rating on Zenas Biopharma (ZBIO)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: ZBIO) | Delayed: 26.87 -1.36 (4.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.23 | 52 Week High | $50.95 | |||
| Open | $28.00 | 52 Week Low | $18.06 | |||
| Day High | $28.33 | P/E | N/A | |||
| Day Low | $26.73 | EPS | $0.00 | |||
| Volume | 377,550 | |||||
